Dr. Tucker is Co-Founder and Chief Operating Officer of Aronora, Inc., an emerging biotechnology company. He is an inventor of several pioneering molecular-targeted therapies that are currently under development to treat significant blood clotting diseases, including heart attack and stroke. Dr. Tucker completed his B.S. in Biochemistry at the University of Oregon and Ph.D. in Biomedical Engineering at Oregon Health & Science University. He has authored >30 scientific publications, and has received several prestigious awards including a Young Investigator Award from the International Society on Thrombosis & Haemostasis, a T32 National Research Service Award from the National Institutes of Health (NIH), and was one of the Portland Business Journal's Forty under 40 class of 2015. He has raised >$21 million in non-dilutive NIH Small Business funding to help advance Aronora’s innovative therapeutic candidates into the clinic.